↓ Skip to main content

Development of a new fully human anti-CD20 monoclonal antibody for the treatment of B-cell malignancies

Overview of attention for article published in Investigational New Drugs, July 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (73rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

patent
32 patents

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
34 Mendeley
Title
Development of a new fully human anti-CD20 monoclonal antibody for the treatment of B-cell malignancies
Published in
Investigational New Drugs, July 2009
DOI 10.1007/s10637-009-9291-z
Pubmed ID
Authors

Gadi Gazit Bornstein, Christophe Quéva, Mohammad Tabrizi, Anne van Abbema, Carlos Chavez, Ping Wang, Orit Foord, Kiran Ahluwalia, Naomi Laing, Sandhya Raja, Shenghua Wen, Larry L. Green, Xiaodong Yang, Carl Webster, Ross Stewart, David Blakey

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 3%
Unknown 33 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 32%
Student > Ph. D. Student 4 12%
Other 3 9%
Professor > Associate Professor 3 9%
Student > Master 3 9%
Other 8 24%
Unknown 2 6%
Readers by discipline Count As %
Agricultural and Biological Sciences 13 38%
Biochemistry, Genetics and Molecular Biology 5 15%
Medicine and Dentistry 5 15%
Immunology and Microbiology 3 9%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Other 2 6%
Unknown 5 15%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 December 2023.
All research outputs
#4,903,595
of 23,572,442 outputs
Outputs from Investigational New Drugs
#172
of 1,197 outputs
Outputs of similar age
#20,917
of 112,333 outputs
Outputs of similar age from Investigational New Drugs
#6
of 14 outputs
Altmetric has tracked 23,572,442 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,197 research outputs from this source. They receive a mean Attention Score of 4.8. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 112,333 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.